Alzheimer's disease

An analysis of brains at various stages of Alzheimer's found that neurons called inhibitory neurons are the first to be affected by the disease.

The antiviral drug also used to treat hepatitis B may help slow cognitive decline.

The FDA recently approved the anti-amyloid drug donanemab, sold as Kisunla. The medication can delay cognitive decline in early Alzheimer's patients by about seven months, but it is expensive and can have serious side effects. Still, it will be soon be available for some patients in South Texas.

As President Joe Biden and former President Donald Trump prepare to take the stage for Thursday’s presidential debate, will they address an important question: How will they tackle Alzheimer’s, the most pressing public health crisis of our time?

When an Alzheimer’s diagnosis happens, a wave of people are affected, and for many that means becoming a caregiver for loved ones.

Border counties in Texas have some of the highest Alzheimer’s diagnosis rates in the nation, with rates ranging from 13% to 18% of people aged 65 and over.

NPR's A Martinez talks to Mario Tapia, founder of the Latino Center on Aging, and Maria Aranda of the USC Edward R. Roybal Institute on Aging, about quality care issues once a diagnosis is made.

Harvard Law School professor and noted defense attorney Charles Ogletree has died at age 70.

Some literature points to pollution and other environmental factors as putting residents at higher risk for the disease, but researchers are exploring other potential causes.

The first drug found to slow the progression of Alzheimer's disease has been granted full approval by the Food and Drug Administration.